As of 2026-05-21, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (14.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.14 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -194.3%.
The range of the Relative Valuation is (13.14) - (14.66) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 17.8x | 17.6x |
| Forward P/E multiples | 15.0x - 19.1x | 17.0x |
| Fair Price | (13.14) - (14.66) | (14.28) |
| Upside | -186.8% - -196.8% | -194.3% |
| Date | P/E |
| 2026-05-20 | -18.34 |
| 2026-05-19 | -17.95 |
| 2026-05-18 | -18.11 |
| 2026-05-15 | -18.06 |
| 2026-05-14 | -18.58 |
| 2026-05-13 | -17.93 |
| 2026-05-12 | -17.78 |
| 2026-05-11 | -17.61 |
| 2026-05-08 | -17.89 |
| 2026-05-07 | -18.34 |
| 2026-05-06 | -18.31 |
| 2026-05-05 | -18.11 |
| 2026-05-04 | -17.62 |
| 2026-05-01 | -17.99 |
| 2026-04-30 | -15.08 |
| 2026-04-29 | -15.01 |
| 2026-04-28 | -18.48 |
| 2026-04-27 | -19.20 |
| 2026-04-24 | -18.62 |
| 2026-04-23 | -18.68 |
| 2026-04-22 | -18.83 |
| 2026-04-21 | -18.22 |
| 2026-04-20 | -19.16 |
| 2026-04-17 | -19.38 |
| 2026-04-16 | -18.64 |
| 2026-04-15 | -18.51 |
| 2026-04-14 | -18.53 |
| 2026-04-13 | -18.04 |
| 2026-04-10 | -17.88 |
| 2026-04-09 | -18.44 |
| 2026-04-08 | -18.42 |
| 2026-04-07 | -18.07 |
| 2026-04-06 | -17.87 |
| 2026-04-02 | -17.93 |
| 2026-04-01 | -18.14 |
| 2026-03-31 | -17.56 |
| 2026-03-30 | -17.11 |
| 2026-03-27 | -17.30 |
| 2026-03-26 | -17.87 |
| 2026-03-25 | -17.64 |
| 2026-03-24 | -17.30 |
| 2026-03-23 | -17.28 |
| 2026-03-20 | -16.78 |
| 2026-03-19 | -17.18 |
| 2026-03-18 | -17.09 |
| 2026-03-17 | -17.58 |
| 2026-03-16 | -17.39 |
| 2026-03-13 | -17.20 |
| 2026-03-12 | -17.32 |
| 2026-03-11 | -17.39 |